"I would be shocked if this stock over the next 5 years is still trading for $85 per share. I'm not a short seller. Every time I talk about a stock negatively, I get comments like, 'Well, then why don't you short it, Daniel?' I'm just telling you that the fundamentals of this business are terrible and it's massively overvalued. This company has a $43 billion valuation, is trading at 10 times sales despite losing money, and all around, this company screams red flags to me."
The speaker provides a comprehensive commentary on Cororeweave, highlighting severe concerns including its overvaluation, deteriorating profitability, heavy debt burden, and insider selling. Although not a direct trade call, the analysis implies significant downside risk for the stock.
META Stock Is Looking Like A Buy + Why CRWV Is Crashing
Daniel Pronk
November 13, 2025
Other